Peer-reviewed veterinary case report
Management of canine atopic dermatitis. Part 1: treatment and management of flare-ups
- Journal:
- The Veterinary Nurse
- Year:
- 2025
- Authors:
- Kerr, Abigail & Gow, Debbie
- Affiliation:
- BVSc BSc(Hons) PgC(SAD) MRCVS, Advanced Practitioner in Veterinary Dermatology
- Species:
- dog
Plain-English summary
Canine atopic dermatitis is a long-lasting skin condition that affects about 3 to 15% of dogs, causing intense itching, skin problems, and infections. This condition can be tough on both dogs and their owners. To manage it, veterinarians often use medications like glucocorticoids, oclacitinib, lokivetmab, and ciclosporin, along with topical treatments to help with inflammation and skin health. For some dogs, a special treatment called allergen-specific immunotherapy can provide lasting relief. Regular check-ups and educating pet owners are important for getting the best results in managing this condition.
Abstract
Canine atopic dermatitis is a chronic inflammatory skin condition affecting 3–15% of dogs, leading to pruritus, skin barrier dysfunction and secondary infections. It significantly impacts canine welfare and caregiver burden. Management involves systemic therapies such as glucocorticoids, oclacitinib, lokivetmab and ciclosporin, alongside topical treatments to control inflammation, infections and skin barrier health. Allergen-specific immunotherapy offers long-term benefits in suitable cases. Regular monitoring through veterinary nurse clinics and caregiver education is essential for optimising outcomes. This article outlines evidence-based strategies for managing canine atopic dermatitis, balancing acute relief with long-term control.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://doi.org/10.12968/vetn.2025.0014